| ARDS patients (n = 40) | Healthy controls (n = 40) | P |
---|---|---|---|
HDL-C, mmol/Lb | 0.55 (0.40–0.88) | 1.46 (1.15–1.92) |  < 0.0001 |
apoA-I, μg/mlb | 35.6 (24.0–43.0) | 88.5 (70.3–111.7) |  < 0.0001 |
apoA-II, μg/mlb | 32.0 (22.3–45.9) | 58.0 (48.3–70.9) |  < 0.0001 |
apoA-IV, μg/mlb | 7.5 (3.8–13.3) | 28.7 (24.1–35.5) |  < 0.0001 |
apoC-III, μg/mlb | 22.6 (21.1–25.0) | 25.9 (23.7–28.7) |  < 0.0001 |
apoE, μg/mla | 28.5 ± 1.0 | 20.6 ± 0.8 |  < 0.0001 |
MPO, μg/mlb | 0.6 (0.3–1.0) | 0.7 (0.4–1.0) | 0.61 |
PON1, ng/mlb | 5.5 (4.2–7.1) | 7.0 (6.1–9.1) |  < 0.0001 |
MPO/PON1b | 105.8 (41.1–193.8) | 91.9 (58.8–129.6) | 0.28 |